Actively Recruiting
The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders
Led by Second Affiliated Hospital of Soochow University · Updated on 2025-02-14
20
Participants Needed
1
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Researchers are evaluating new and precise neuromodulation methods to treat sleep-wake disorders like insomnia, narcolepsy, and REM sleep behavior disorder. The study focuses on using phototherapy, transcranial electrical stimulation, and magnetic stimulation to explore effective ways to improve sleep through controlled interventions. This research is conducted by the Second Affiliated Hospital of Soochow University and aims to advance neuromodulation technologies for these conditions. Participants in this study will experience one of several interventions including repetitive transcranial magnetic stimulation, transcranial direct current stimulation, or daytime timed bright light exposure. These treatments are delivered as device-based therapies to regulate brain activity related to sleep. The treatment period lasts about 4 weeks, during which participants receive the assigned neuromodulation intervention. During the study, participants will undergo evaluations using objective sleep measures and clinical sleep-related scales from enrollment through the 4-week treatment. Additional assessments include resting-state electroencephalogram (EEG), functional magnetic resonance imaging (fMRI), and blood biochemical tests to monitor changes. The study does not use masking or blinding, and participants will be closely monitored throughout the treatment period to assess outcomes and safety.
CONDITIONS
Brief Title
The Impact of Light, Electrical, and Magnetic Neuroregulation Interventions on Sleep-wake Disorders
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patients with insomnia, narcolepsy, and REM sleep behavior disorder clearly diagnosed by specialists
- Signed informed consent form
- Aged between 8 and 75 years
You will not qualify if you...
- Major neurological diseases such as multi-infarct dementia, Huntington's disease, normal pressure hydrocephalus, brain tumors, progressive supranuclear palsy, epilepsy, subdural hematoma, multiple sclerosis, or structural brain abnormalities after head trauma
- History of major depressive disorder, bipolar disorder within the past year, or schizophrenia
- Severe drug or alcohol abuse within the past year
- Significant systemic illness or unstable medical condition such as severe autoimmune diseases or history of cancer
- Significant hearing, visual, or cognitive impairments preventing meaningful participation in interviews
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 4 weeks
Participants receive neuroregulation interventions such as transcranial magnetic stimulation, transcranial direct current stimulation, or daytime timed bright light exposure to address sleep-wake disorders.
Weekly visits for up to 4 weeks
Trial Site Locations
Total: 1 location
1
Department of Neurology, Second Affiliated Hospital of Soochow University
Suzhou, Jiangsu, China, 215004
Actively Recruiting
Research Team
C
Chun-Feng Liu, PhD
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here